HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-κB inhibition

Life Sci. 2017 Jan 15:169:11-19. doi: 10.1016/j.lfs.2016.10.031. Epub 2016 Nov 22.

Abstract

Cancer patients often show a wasting syndrome for which there are little therapeutic options. Dietary polyphenols have been proposed for treating this syndrome, but their usefulness in cases associated with human papillomavirus (HPV)-induced cancers is unknown. We characterized HPV16-transgenic mice as a model of cancer cachexia and tested the efficacy of long-term oral supplementation with polyphenols curcumin and rutin. Both compounds were orally administered to six weeks-old HPV16-transgenic mice showing characteristic multi-step skin carcinogenesis, for 24weeks. Skin lesions and blood, liver and spleen inflammatory changes were characterized histologically and hematologically. Hepatic oxidative stress, skeletal muscle mass and the levels of muscle pro-inflammatory transcription factor NF-κB were also assessed. Skin carcinogenesis was associated with progressive, severe, systemic inflammation (leukocytosis, hepatitis, splenitis), significant mortality and cachexia. Curcumin and rutin totally suppressed mortality while reducing white blood cells and the incidence of splenitis and hepatitis. Rutin prevented muscle wasting more effectively than curcumin. Preservation of muscle mass and reduced hepatic inflammation were associated with down-regulation of the NF-κB canonical pathway and with reduced oxidative stress, respectively. These results point out HPV16-transgenic mice as a useful model for studying the wasting syndrome associated with HPV-induced cancers. Dietary NF-κB inhibitors may be useful resources for treating this syndrome.

Keywords: Cachexia; Cancer; Curcumin; HPV; NF-κB; Rutin.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cachexia / complications
  • Cachexia / drug therapy*
  • Cachexia / pathology
  • Cachexia / virology
  • Curcumin / therapeutic use*
  • Female
  • Human papillomavirus 16 / immunology*
  • Humans
  • Inflammation / complications
  • Inflammation / drug therapy
  • Inflammation / pathology
  • Inflammation / virology
  • Mice, Transgenic
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / virology
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / immunology
  • Rutin / therapeutic use*
  • Skin / drug effects
  • Skin / pathology
  • Skin / virology
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / virology
  • Wasting Syndrome / complications
  • Wasting Syndrome / drug therapy
  • Wasting Syndrome / pathology
  • Wasting Syndrome / virology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • NF-kappa B
  • Rutin
  • Curcumin